PDCD1 and neoplasm: Loss of phosphatase and tensin homolog (PTEN) as well as activation of PI3K-AKT pathway in tumor cells brings about increased immunosuppressive cytokines and attenuated T-cell infiltration and activity, thereby promoting resistance to PD-1 inhibitor therapy (Peng et al., 2016).